Lessons learned from pompe disease newborn screening and follow-up

20Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

In 2015, Pompe disease became the first lysosomal storage disorder to be recommended for universal newborn screening by the Secretary of the U.S. Department of Health and Human Services. Newborn screening for Pompe has been implemented in 20 states and several countries across the world. The rates of later-onset disease phenotypes for Pompe and pseudodeficiency alleles are higher than initially anticipated, and these factors must be considered during Pompe disease newborn screening. This report presents an overview of six years of data from the Missouri State Public Health Laboratory for Pompe disease newborn screening and follow-up.

Cite

CITATION STYLE

APA

Klug, T. L., Swartz, L. B., Washburn, J., Brannen, C., & Kiesling, J. L. (2020). Lessons learned from pompe disease newborn screening and follow-up. International Journal of Neonatal Screening, 6(1). https://doi.org/10.3390/ijns6010011

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free